Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 11,525,089 16.900% |
2,054,597 (+21.69%) |
Filing History |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital International Investors | 5,629,453 8.300% |
-1,270,040 (-18.41%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
The Vanguard Group | 5,920,568 8.690% |
270,183 (+4.78%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
BLACKROCK INC BLK |
3,484,652 5.100% |
-1,802,824 (-34.10%) |
Filing History |
| 2021-10-26 4:44 pm Sale |
2021-10-21 | 13D | Arcturus Therapeutics Holdings Inc. ARCT |
Ultragenyx Pharmaceutical Inc. RARE |
1,200,000 4.600% |
-200,000 (-14.29%) |
Filing History |
| 2021-10-08 2:08 pm Sale |
2021-10-12 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital Research Global Investors | 3,361,792 5.000% |
-3,900,109 (-53.71%) |
Filing History |
| 2021-08-12 5:09 pm Sale |
2021-08-10 | 13D | Arcturus Therapeutics Holdings Inc. ARCT |
Ultragenyx Pharmaceutical Inc. RARE |
1,400,000 5.300% |
-800,000 (-36.36%) |
Filing History |
| 2021-02-16 4:04 pm Purchase |
2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital International Investors | 6,899,493 10.500% |
304,831 (+4.62%) |
Filing History |
| 2021-02-16 1:24 pm Sale |
2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital World Investors | 3,129,724 4.700% |
-107,571 (-3.32%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital Research Global Investors | 7,261,901 11.000% |
899,206 (+14.13%) |
Filing History |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 9,470,492 14.300% |
2,851,572 (+43.08%) |
Filing History |
| 2021-02-12 1:06 pm Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
FEDERATED HERMES INC. FHI |
4,280,528 6.470% |
1,308,520 (+44.03%) |
Filing History |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
The Vanguard Group | 5,650,385 8.570% |
797,226 (+16.43%) |
Filing History |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
BLACKROCK INC BLK |
5,287,476 8.000% |
554,392 (+11.71%) |
Filing History |
| 2020-12-10 4:51 pm Sale |
2020-12-08 | 13D | Arcturus Therapeutics Holdings Inc. ARCT |
Ultragenyx Pharmaceutical Inc. RARE |
2,200,000 9.000% |
-800,000 (-26.67%) |
Filing History |
| 2020-11-06 4:16 pm Purchase |
2020-10-22 | 13D | Solid Biosciences Inc. SLDB |
Ultragenyx Pharmaceutical Inc. RARE |
521,720 14.500% |
521,720 (New Position) |
Filing History |
| 2020-05-22 5:21 pm Purchase |
2020-05-20 | 13D | Arcturus Therapeutics Holdings Inc. ARCT |
Ultragenyx Pharmaceutical Inc. RARE |
3,000,000 14.600% |
321,964 (+12.02%) |
Filing History |
| 2020-05-11 1:21 pm Purchase |
2020-04-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 6,618,920 11.100% |
2,127,151 (+47.36%) |
Filing History |